ESAB Q2 Earnings Weighed Down by Eddyfi Deal Costs and Restructuring; Sales Climb 13%
ESAB is trading near its 52-week low of $82.185 (12% above the low).
Summary
ESAB's Q2 2026 net income fell sharply to $36M from $70M a year ago, weighed down by Eddyfi acquisition costs, higher restructuring charges, and increased interest expense, even as sales rose 13% to $808M.
Key Events · Earnings and Guidance · ESAB
-
Net Income Halves on Deal Costs
Net income from continuing operations fell to $36.4M in Q2 2026 from $69.8M a year earlier, driven by $24.8M in transaction and integration costs, $18.3M in restructuring charges, and a $9.6M increase in interest expense.
-
Sales Rise 13% on Eddyfi Boost
Net sales increased 13% to $807.6M, with the Eddyfi acquisition contributing $21.4M. Organic sales grew 2.5%, driven by pricing gains.
-
Debt Load Doubles to $2.4B
Total debt surged to $2.4B from $1.2B at year-end 2025, reflecting the $1B senior notes issuance and revolver drawdowns to fund the Eddyfi acquisition.
-
Restructuring Charges Spike
Restructuring and other related charges jumped to $18.3M from $1.4M in Q2 2025, primarily from strategic initiatives to improve margins in the Americas.
Analysis · ESAB · Technology
The second quarter reveals the steep integration bill for ESAB's $1.5B Eddyfi acquisition. While net sales rose 13% to $808M, net income from continuing operations was nearly cut in half to $36M as restructuring charges surged and interest expense more than doubled. The balance sheet has been transformed — total debt now stands at $2.4B, up from $1.2B at year-end, reflecting the deal financing. Adjusted EBITDA edged up to $151M, but margins compressed. The company also granted performance-based options with aggressive $140–$200 stock price hurdles, signaling management's long-term confidence but also adding future dilution risk.
At the time of this filing, ESAB was trading at $92.01 on NYSE in the Technology sector, with a market capitalization of approximately $5.6B. The 52-week trading range was $82.19 to $137.42. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.